137 related articles for article (PubMed ID: 8333745)
1. [Surgical adjuvant therapy of carcinoma of the thoracic esophagus].
Kakegawa T; Yamana H; Fujita H; Shinozaki K
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1173-8. PubMed ID: 8333745
[TBL] [Abstract][Full Text] [Related]
2. [Problems and present status of clinical trials for esophageal carcinoma].
Hayashi K; Ide H
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():348-55. PubMed ID: 7986114
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
Ando N; Ozawa S; Kitajima M; Iizuka T
Gan To Kagaku Ryoho; 1995 Jun; 22(7):869-76. PubMed ID: 7540823
[TBL] [Abstract][Full Text] [Related]
4. [Multidisciplinary treatment of cancer of the esophagus].
Hoshino A; Nishihira T; Hirayama K; Shineha R; Mori S
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1141-6. PubMed ID: 8333741
[TBL] [Abstract][Full Text] [Related]
5. [Progress of postoperative adjuvant therapies for esophageal cancer].
Terashima M; Kogure M; Gotoh M
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2475-80. PubMed ID: 12506469
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
7. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.
Shiozaki A; Yamagishi H; Itoi H; Fujiwara H; Kikuchi S; Okamoto K; Ichikawa D; Fuji N; Ochiai T; Sonoyama T; Ueda Y
Oncol Rep; 2005 Apr; 13(4):667-72. PubMed ID: 15756440
[TBL] [Abstract][Full Text] [Related]
8. [Postoperative adjuvant therapies for esophageal carcinoma].
Kuwano H; Ojima H; Kato H
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2023-7. PubMed ID: 11103232
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus.
Roth JA; Pass HI; Flanagan MM; Graeber GM; Rosenberg JC; Steinberg S
J Thorac Cardiovasc Surg; 1988 Aug; 96(2):242-8. PubMed ID: 2456424
[TBL] [Abstract][Full Text] [Related]
10. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.
Ando N; Iizuka T; Ide H; Ishida K; Shinoda M; Nishimaki T; Takiyama W; Watanabe H; Isono K; Aoyama N; Makuuchi H; Tanaka O; Yamana H; Ikeuchi S; Kabuto T; Nagai K; Shimada Y; Kinjo Y; Fukuda H;
J Clin Oncol; 2003 Dec; 21(24):4592-6. PubMed ID: 14673047
[TBL] [Abstract][Full Text] [Related]
11. [Effects of combined therapy with irradiation, cisplatin and vindesine in lymph node recurrence of esophageal cancer].
Okuyama K; Onoda S; Kouzu T; Tohnosu N; Koide Y; Awano T; Matubara H; Sano T; Kinosita H; Nakaichi H
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3173-7. PubMed ID: 2782913
[TBL] [Abstract][Full Text] [Related]
12. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
13. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
Fujita H; Sueyoshi S; Tanaka T; Tanaka Y; Sasahara H; Shirouzu K; Suzuki G; Hayabuchi N; Inutsuka H
J Surg Oncol; 2005 Jun; 90(4):209-19. PubMed ID: 15906363
[TBL] [Abstract][Full Text] [Related]
14. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of esophageal carcinoma].
Iizuka T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):597-601. PubMed ID: 3355181
[TBL] [Abstract][Full Text] [Related]
16. [Inoperable esophageal carcinoma managed by combined chemotherapy (CBDCA, 5-FU and VDS) and radiotherapy].
Morishima Y; Tashiro T; Yamamori H; Takagi K; Ohtsubo Y; Sugiura T; Hayashi N; Furukawa K; Itabashi T; Sano W; Toyoda Y; Nitta H; Nakajima N
Gan To Kagaku Ryoho; 1997 Jun; 24(8):965-9. PubMed ID: 9212805
[TBL] [Abstract][Full Text] [Related]
17. Optimal treatment for localized esophageal cancer still uncertain.
Lord RV
Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
[TBL] [Abstract][Full Text] [Related]
18. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
20. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.
Bédard EL; Inculet RI; Malthaner RA; Brecevic E; Vincent M; Dar R
Cancer; 2001 Jun; 91(12):2423-30. PubMed ID: 11413534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]